Pages that link to "Q39972823"
Jump to navigation
Jump to search
The following pages link to Respiratory microbiology of patients with cystic fibrosis in the United States, 1995 to 2005. (Q39972823):
Displaying 50 items.
- Airway microbiota and pathogen abundance in age-stratified cystic fibrosis patients (Q21562196) (← links)
- Treatment for chronic methicillin-sensitive Staphylococcus aureus pulmonary infection in people with cystic fibrosis (Q24186014) (← links)
- Treatment for chronic Staphylococcus aureus pulmonary infection in people with cystic fibrosis (Q24187701) (← links)
- Tobramycin Inhalation Powder (TIP): An Efficient Treatment Strategy for the Management of Chronic Pseudomonas Aeruginosa Infection in Cystic Fibrosis (Q26829604) (← links)
- Stenotrophomonas maltophilia: an emerging global opportunistic pathogen (Q26995336) (← links)
- The Role of Bacterial Secretion Systems in the Virulence of Gram-Negative Airway Pathogens Associated with Cystic Fibrosis (Q28068051) (← links)
- Respiratory infection rates differ between geographically distant paediatric cystic fibrosis cohorts (Q28589362) (← links)
- Activation of the pyrin inflammasome by intracellular Burkholderia cenocepacia (Q30527774) (← links)
- Longitudinal survey of Staphylococcus aureus in cystic fibrosis patients using a multiple-locus variable-number of tandem-repeats analysis method (Q33526875) (← links)
- The effects of inhaled aztreonam on the cystic fibrosis lung microbiome. (Q33644835) (← links)
- Measuring and improving respiratory outcomes in cystic fibrosis lung disease: opportunities and challenges to therapy (Q33697276) (← links)
- Genomic analysis and relatedness of P2-like phages of the Burkholderia cepacia complex (Q33727287) (← links)
- Multicenter Observational Study on Factors and Outcomes Associated with Various Methicillin-Resistant Staphylococcus aureus Types in Children with Cystic Fibrosis (Q33783497) (← links)
- The changing microbial epidemiology in cystic fibrosis (Q33825634) (← links)
- Cystic fibrosis pigs develop lung disease and exhibit defective bacterial eradication at birth (Q33929671) (← links)
- Adaptive evolution of Staphylococcus aureus during chronic endobronchial infection of a cystic fibrosis patient (Q34017905) (← links)
- Characterization of macrolide resistance genes in Haemophilus influenzae isolated from children with cystic fibrosis (Q34150150) (← links)
- The adult cystic fibrosis airway microbiota is stable over time and infection type, and highly resilient to antibiotic treatment of exacerbations (Q34437958) (← links)
- Clinical Significance of Microbial Infection and Adaptation in Cystic Fibrosis (Q34491552) (← links)
- Emergence of linezolid-resistant Staphylococcus aureus after prolonged treatment of cystic fibrosis patients in Cleveland, Ohio (Q34737606) (← links)
- Development and antimicrobial susceptibility studies of in vitro monomicrobial and polymicrobial biofilm models with Aspergillus fumigatus and Pseudomonas aeruginosa (Q35109394) (← links)
- Adaptation of Pseudomonas aeruginosa in Cystic Fibrosis airways influences virulence of Staphylococcus aureus in vitro and murine models of co-infection (Q35113179) (← links)
- Pseudomonas aeruginosa in cystic fibrosis patients with G551D-CFTR treated with ivacaftor (Q35127240) (← links)
- Reduction in Pseudomonas aeruginosa sputum density during a cystic fibrosis pulmonary exacerbation does not predict clinical response (Q35358667) (← links)
- Lung microbiota across age and disease stage in cystic fibrosis (Q35605802) (← links)
- Clinical outcomes associated with Staphylococcus aureus and Pseudomonas aeruginosa airway infections in adult cystic fibrosis patients (Q35669548) (← links)
- The cystic fibrosis microbiome in an ecological perspective and its impact in antibiotic therapy (Q35861377) (← links)
- Outcomes and Treatment of Chronic Methicillin-Resistant Staphylococcus aureus Differs by Staphylococcal Cassette Chromosome mec (SCCmec) Type in Children With Cystic Fibrosis (Q36009637) (← links)
- The Dynamics of Disease Progression in Cystic Fibrosis (Q36036190) (← links)
- Lung transplantation for cystic fibrosis: results, indications, complications, and controversies (Q36658777) (← links)
- Proteome Analyses of Staphylococcus aureus Biofilm at Elevated Levels of NaCl (Q36672783) (← links)
- Molecular characterization of Achromobacter isolates from cystic fibrosis and non-cystic fibrosis patients in Madrid, Spain (Q37026521) (← links)
- Staphylococcus aureus small-colony variants are independently associated with worse lung disease in children with cystic fibrosis (Q37463364) (← links)
- Twenty-five-year outbreak of Pseudomonas aeruginosa infecting individuals with cystic fibrosis: identification of the prairie epidemic strain. (Q37713415) (← links)
- Aztreonam lysine: a novel inhalational antibiotic for cystic fibrosis (Q37775620) (← links)
- The impact of methicillin-resistant Staphylococcus aureus colonisation on paediatric cystic fibrosis patients' morbidity. (Q37779250) (← links)
- Challenging and emerging pathogens in cystic fibrosis (Q37812469) (← links)
- Therapeutics Development for Cystic Fibrosis: A Successful Model for a Multisystem Genetic Disease (Q37827865) (← links)
- Stenotrophomonas maltophilia: emerging disease patterns and challenges for treatment. (Q37866819) (← links)
- Review: Staphylococcus aureus and MRSA in cystic fibrosis (Q37896351) (← links)
- Inhaled antibiotics for gram-negative respiratory infections (Q37937558) (← links)
- Tobramycin Inhalation Powder™: a novel drug delivery system for treating chronic Pseudomonas aeruginosa infection in cystic fibrosis (Q37940005) (← links)
- Current dilemmas in antimicrobial therapy in cystic fibrosis. (Q38042719) (← links)
- Staphylococcus aureus in early cystic fibrosis lung disease (Q38130897) (← links)
- Nontuberculous mycobacteria: the changing epidemiology and treatment challenges in cystic fibrosis. (Q38139191) (← links)
- Emerging drugs for cystic fibrosis. (Q38183476) (← links)
- Tobramycin inhalation powder: an efficient and efficacious therapy for the treatment of Pseudomonas aeruginosa infection in cystic fibrosis (Q38358856) (← links)
- Long-term safety and efficacy of tobramycin in the management of cystic fibrosis (Q38384994) (← links)
- First Description of an RND-Type Multidrug Efflux Pump in Achromobacter xylosoxidans, AxyABM (Q38627088) (← links)
- The art of persistence-the secrets to Burkholderia chronic infections. (Q38839466) (← links)